Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2017: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
PAH mice and Sham mice were orally administered the Ca leak inhibitor dantrolene, and the right ventricular pressure was measured, the cardiomyocyte size was measured, Ca transient observation, fixed and anti-CaM, anti-GRK 5, anti-HDAC 4, 5, anti Immunostaining was performed with antibodies of -p-HDAC 4, 5. As a result, oral administration of dantrolene did not affect pulmonary artery pressure. In the oral administration group of dantrolene, myocardial cell size was reduced and the hypertrophy was suppressed. Furthermore, reduction of RyR bound CaM was suppressed. From this, it was suggested that dantrolene inhibited the dissociation of CaM from RyR, thus suppressing hypertrophy.
|